News & Information 

At Memorial Sloan Kettering, our leading edge research is constantly advancing what we know about cancer and new discoveries are improving care for patients here, and all over the world. In News and Information, you will find information about our groundbreaking work and the dedicated professionals who make it all happen.

For Journalists

Connect with us to reach MSK experts for media inquiries, source story ideas and download MSK digital assets.

Learn more

Trending Topics
Dr. Jun Mao with patient
During the upcoming ASCO Virtual Scientific Program, MSK Chief of Integrative Medicine, Jun J. Mao, MD, MSCE will be presenting a new study comparing the effectiveness of electro-acupuncture (EA) and auricular acupuncture (AA) versus usual care (UC) for chronic musculoskeletal pain in cancer survivors.
Dr.  Zsofia Stadler
During the upcoming ASCO Virtual Scientific Program, MSK Medical Oncologist Zsofia K. Stadler, MD, will present a study where she and her team sought to assess the clinical utility of germline mutation profiling for targeted therapeutic interventions in a pan-cancer patient population, or a population with similarities and differences among the genomic and cellular alterations found across their diverse tumor types.
Charles Rudin with lab member
During the upcoming ASCO Virtual Scientific Program, MSK Chief of Thoracic Oncology Service Charles M. Rudin, MD, PhD, will present a study that found pembrolizumab addition to first-line chemotherapy significantly improved progression-free survival for patients with small cell lung cancer (SCLC).
View all trending topics
News Releases
MSK radiologist reviews a scan
As the height of the COVID-19 outbreak in New York City and the Tri-State area begins to subside, oncologists at Memorial Sloan Kettering Cancer Center (MSK) are urging patients to schedule cancer screenings and treatments now.
Rona Yaeger, MD, Co-First author (on the left) and Sandra Misale PhD, senior author (on the right).
An international team of researchers led by Sandra Misale, research associate at the Sloan Kettering Institute, examined the effects of the experimental cancer drug, AMG510, which targets KRAS G12C cell lines, and found that the efficacy of such KRAS G12C inhibitors is lineage-specific. These findings provide a mechanistic understanding of the differences in response to KRAS G12C inhibitor in lung and colorectal cancers.
View all news releases

MSK in the News


MSK patient Eliza Paris is featured on her experience with COVID-19. 
Thursday, May 28, 2020
If financial worries are top of mind, the last thing you may feel like doing is laughing. Yet perhaps you should. MSK’s Julia Kearney is quoted.
Thursday, May 28, 2020
MSK’s Diane Reidy-Lagunes is interviewed on how the COVID-19 pandemic is changing healthcare and discusses MSK’s telehealth program and catering to differing age groups, from millennials to baby boomers.
Wednesday, May 27, 2020

View all media coverage
MSK News
View all MSK News
On Cancer Blog
View all blog posts
Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
Upcoming Events
Find a complete list of events at MSK for everyone from patients and caregivers to physicians and researchers.
View all events